terazosin has been researched along with phentolamine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bondinell, WE; Hieble, JP; Ruffolo, RR | 1 |
| Arredondo, NF; Bantle, GW; Blue, DR; Clarke, DE; DeSousa, A; Elworthy, TR; Ford, AP; Gross, LM; Kava, MS; Lesnick, JD; Morgans, DJ; Ozer, RS; Palmer, WS; Pfister, JR; Repke, DB; Romero, M; Sandoval, L; Sjogren, EB; Talamás, FX; Vazquez, A; Vimont, RL; Williams, TJ; Wu, H; Zhu, QM | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bednarski, M; Dudek, M; Kulig, K; Lustyk, K; Malawska, B; Nowiński, L; Raźny, K; Sapa, J; Siwek, A; Starowicz, G; Zaręba, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Kinami, J; Maruyama, K; Nagatomo, T; Tsuchihashi, H | 1 |
| Abadir, AR; Alver, JE; Gintautas, J; Kester, RR; Kim, H; Mooppan, UM | 1 |
| Hanazuka, M; Horii, D; Mizogami, S | 1 |
| Frisk-Holmberg, M | 1 |
| Chiba, T; Fukutomi, J; Hattori, K; Maruyama, K; Nagatomo, T; Takeda, M; Yamaguchi, M | 1 |
| Bayne, ML; Burns, HD; Chang, RS; Chen, TB; DiSalvo, J; Francis, BE; Gibson, RE; Gluchowski, C; Marzabadi, M; Nagarathnam, D; O'Malley, SS; Wetzel, JM | 1 |
| Hieble, JP; McCafferty, GP; Naselsky, DP | 1 |
| Du, H; He, L; Ren, J; Wang, S | 1 |
2 review(s) available for terazosin and phentolamine
| Article | Year |
|---|---|
Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.
Topics: Animals; Humans; Molecular Biology; Molecular Structure; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1995 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for terazosin and phentolamine
| Article | Year |
|---|---|
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Amides; Animals; Binding, Competitive; Humans; Male; Middle Aged; Models, Chemical; Muscle, Smooth; Piperazines; Prazosin; Propylamines; Prostatic Hyperplasia; Rabbits; Rats; Structure-Activity Relationship; Urinary Bladder | 1997 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Hypotension; Male; Molecular Structure; Piperazines; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Binding characteristics of alpha 1-adrenoceptors in bovine prostate using a radioligand binding assay.
Topics: Adrenergic alpha-Antagonists; Animals; Cattle; Kinetics; Male; Membranes; Phentolamine; Prazosin; Prostate; Quinazolines; Radioligand Assay; Receptors, Adrenergic, alpha; Tritium | 1991 |
The effects of the alpha 1-adrenergic antagonists terazosin and phentolamine on prostatic adenoma and urethra in vitro.
Topics: Adenoma; Adrenergic alpha-Antagonists; Humans; In Vitro Techniques; Male; Muscle Contraction; Phentolamine; Prazosin; Prostatic Neoplasms; Urethra | 1989 |
[Alpha-adrenoceptor blocking action of terazosin].
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta; Decerebrate State; Heart Rate; Male; Phentolamine; Prazosin; Rats; Rats, Inbred Strains; Vasodilator Agents; Yohimbine | 1986 |
Effect of clonidine at steady state on blood pressure in spontaneously hypertensive rats. Interaction of various alpha-adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Animals; Benzimidazoles; Blood Pressure; Clonidine; Dioxanes; Drug Interactions; Hypertension; Male; Phentolamine; Piperazines; Prazosin; Rats; Rats, Inbred Strains; Yohimbine | 1984 |
Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Binding, Competitive; Dioxanes; Humans; In Vitro Techniques; Kinetics; Male; Nifedipine; Phentolamine; Piperazines; Prazosin; Prostate; Protein Binding; Radioligand Assay; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tritium | 1996 |
Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissues.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Amidines; Animals; Binding, Competitive; Cerebral Cortex; Dihydropyridines; Hippocampus; Humans; Iodine Radioisotopes; Kidney; Male; Myocardium; Phentolamine; Piperidines; Prazosin; Prostate; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Vas Deferens | 1998 |
Characterization of postjunctional alpha-adrenoceptors in the pithed mouse.
Topics: 3T3 Cells; Adrenergic alpha-Antagonists; Animals; Azepines; Binding, Competitive; Blood Pressure; CHO Cells; Cricetinae; Decerebrate State; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred C57BL; Neuroeffector Junction; Phentolamine; Phenylephrine; Prazosin; Radioligand Assay; Receptors, Adrenergic, alpha; Recombinant Fusion Proteins; Vasoconstrictor Agents; Yohimbine | 1999 |
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.
Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin | 2011 |